Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Assets Average (2016 - 2025)

Historic Assets Average for Niagen Bioscience (NAGE) over the last 15 years, with Q3 2025 value amounting to $94.8 million.

  • Niagen Bioscience's Assets Average rose 7155.31% to $94.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $94.8 million, marking a year-over-year increase of 7155.31%. This contributed to the annual value of $61.6 million for FY2024, which is 1304.43% up from last year.
  • Per Niagen Bioscience's latest filing, its Assets Average stood at $94.8 million for Q3 2025, which was up 7155.31% from $86.4 million recorded in Q2 2025.
  • Niagen Bioscience's Assets Average's 5-year high stood at $94.8 million during Q3 2025, with a 5-year trough of $46.1 million in Q3 2022.
  • For the 5-year period, Niagen Bioscience's Assets Average averaged around $60.0 million, with its median value being $54.5 million (2024).
  • Its Assets Average has fluctuated over the past 5 years, first tumbled by 2693.4% in 2022, then skyrocketed by 7155.31% in 2025.
  • Over the past 5 years, Niagen Bioscience's Assets Average (Quarter) stood at $59.1 million in 2021, then decreased by 15.7% to $49.9 million in 2022, then rose by 8.75% to $54.2 million in 2023, then increased by 15.08% to $62.4 million in 2024, then surged by 51.97% to $94.8 million in 2025.
  • Its Assets Average was $94.8 million in Q3 2025, compared to $86.4 million in Q2 2025 and $74.8 million in Q1 2025.